Selected research
Market Analysis & Forecast
Global Poultry Vaccines Market Analysis and Forecast 2026-2032
Market perspective
The global Poultry Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Poultry Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Poultry Vaccines include Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike and Phibro Animal Health Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Poultry Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Poultry Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Poultry Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Poultry Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Poultry Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Poultry Vaccines revenue, projected growth trends, production technology, application and end-user industry.
Poultry Vaccines Segment by Company
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Poultry Vaccines Segment by Type
Live
Attenuated
Killed
Poultry Vaccines Segment by Application
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
Poultry Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poultry Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poultry Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poultry Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Poultry Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Poultry Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poultry Vaccines revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live
- Attenuated
- Killed
Applications
- NDV
- Marek ' s Disease
- IBD
- Infectious Bronchitis
- Influenza
- Others
Companies covered
- Merck
- Boehringer Ingelheim
- Ceva
- Zoetis
- Vaxxinova®
- Elanco
- QYH Biotech Co., Ltd
- Pulike
- Phibro Animal Health Corporation
- JinYu Biotechnology
- Harbin Pharmaceutical Group
- MEVAC
- Venky's
- Japfa Comfeed Indonesia
- Nisseiken
- Hile
- Hester Biosciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Poultry Vaccines Market by Type
- 1.2.1 Global Poultry Vaccines Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Live
- 1.2.3 Attenuated
- 1.2.4 Killed
- 1.3 Poultry Vaccines Market by Application
- 1.3.1 Global Poultry Vaccines Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 NDV
- 1.3.3 Marek ' s Disease
- 1.3.4 IBD
- 1.3.5 Infectious Bronchitis
- 1.3.6 Influenza
- 1.3.7 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Poultry Vaccines Market Dynamics
- 2.1 Poultry Vaccines Industry Trends
- 2.2 Poultry Vaccines Industry Drivers
- 2.3 Poultry Vaccines Industry Opportunities and Challenges
- 2.4 Poultry Vaccines Industry Restraints
3 Global Growth Perspective
- 3.1 Global Poultry Vaccines Market Perspective (2021-2032)
- 3.2 Global Poultry Vaccines Growth Trends by Region
- 3.2.1 Global Poultry Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Poultry Vaccines Market Size by Region (2021-2026)
- 3.2.3 Global Poultry Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Poultry Vaccines Revenue by Players
- 4.1.1 Global Poultry Vaccines Revenue by Players (2021-2026)
- 4.1.2 Global Poultry Vaccines Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Poultry Vaccines Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Poultry Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Poultry Vaccines Key Players Headquarters & Area Served
- 4.4 Global Poultry Vaccines Players, Product Type & Application
- 4.5 Global Poultry Vaccines Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Poultry Vaccines Market CR5 and HHI
- 4.6.3 2025 Poultry Vaccines Tier 1, Tier 2, and Tier 3
5 Poultry Vaccines Market Size by Type
- 5.1 Global Poultry Vaccines Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Poultry Vaccines Revenue by Type (2021-2032)
- 5.3 Global Poultry Vaccines Revenue Market Share by Type (2021-2032)
6 Poultry Vaccines Market Size by Application
- 6.1 Global Poultry Vaccines Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Poultry Vaccines Revenue by Application (2021-2032)
- 6.3 Global Poultry Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Merck
- 7.1.1 Merck Company Information
- 7.1.2 Merck Business Overview
- 7.1.3 Merck Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.1.4 Merck Poultry Vaccines Product Portfolio
- 7.1.5 Merck Recent Developments
- 7.2 Boehringer Ingelheim
- 7.2.1 Boehringer Ingelheim Company Information
- 7.2.2 Boehringer Ingelheim Business Overview
- 7.2.3 Boehringer Ingelheim Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.2.4 Boehringer Ingelheim Poultry Vaccines Product Portfolio
- 7.2.5 Boehringer Ingelheim Recent Developments
- 7.3 Ceva
- 7.3.1 Ceva Company Information
- 7.3.2 Ceva Business Overview
- 7.3.3 Ceva Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.3.4 Ceva Poultry Vaccines Product Portfolio
- 7.3.5 Ceva Recent Developments
- 7.4 Zoetis
- 7.4.1 Zoetis Company Information
- 7.4.2 Zoetis Business Overview
- 7.4.3 Zoetis Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.4.4 Zoetis Poultry Vaccines Product Portfolio
- 7.4.5 Zoetis Recent Developments
- 7.5 Vaxxinova®
- 7.5.1 Vaxxinova® Company Information
- 7.5.2 Vaxxinova® Business Overview
- 7.5.3 Vaxxinova® Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.5.4 Vaxxinova® Poultry Vaccines Product Portfolio
- 7.5.5 Vaxxinova® Recent Developments
- 7.6 Elanco
- 7.6.1 Elanco Company Information
- 7.6.2 Elanco Business Overview
- 7.6.3 Elanco Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.6.4 Elanco Poultry Vaccines Product Portfolio
- 7.6.5 Elanco Recent Developments
- 7.7 QYH Biotech Co., Ltd
- 7.7.1 QYH Biotech Co., Ltd Company Information
- 7.7.2 QYH Biotech Co., Ltd Business Overview
- 7.7.3 QYH Biotech Co., Ltd Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.7.4 QYH Biotech Co., Ltd Poultry Vaccines Product Portfolio
- 7.7.5 QYH Biotech Co., Ltd Recent Developments
- 7.8 Pulike
- 7.8.1 Pulike Company Information
- 7.8.2 Pulike Business Overview
- 7.8.3 Pulike Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.8.4 Pulike Poultry Vaccines Product Portfolio
- 7.8.5 Pulike Recent Developments
- 7.9 Phibro Animal Health Corporation
- 7.9.1 Phibro Animal Health Corporation Company Information
- 7.9.2 Phibro Animal Health Corporation Business Overview
- 7.9.3 Phibro Animal Health Corporation Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.9.4 Phibro Animal Health Corporation Poultry Vaccines Product Portfolio
- 7.9.5 Phibro Animal Health Corporation Recent Developments
- 7.10 JinYu Biotechnology
- 7.10.1 JinYu Biotechnology Company Information
- 7.10.2 JinYu Biotechnology Business Overview
- 7.10.3 JinYu Biotechnology Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.10.4 JinYu Biotechnology Poultry Vaccines Product Portfolio
- 7.10.5 JinYu Biotechnology Recent Developments
- 7.11 Harbin Pharmaceutical Group
- 7.11.1 Harbin Pharmaceutical Group Company Information
- 7.11.2 Harbin Pharmaceutical Group Business Overview
- 7.11.3 Harbin Pharmaceutical Group Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.11.4 Harbin Pharmaceutical Group Poultry Vaccines Product Portfolio
- 7.11.5 Harbin Pharmaceutical Group Recent Developments
- 7.12 MEVAC
- 7.12.1 MEVAC Company Information
- 7.12.2 MEVAC Business Overview
- 7.12.3 MEVAC Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.12.4 MEVAC Poultry Vaccines Product Portfolio
- 7.12.5 MEVAC Recent Developments
- 7.13 Venky's
- 7.13.1 Venky's Company Information
- 7.13.2 Venky's Business Overview
- 7.13.3 Venky's Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.13.4 Venky's Poultry Vaccines Product Portfolio
- 7.13.5 Venky's Recent Developments
- 7.14 Japfa Comfeed Indonesia
- 7.14.1 Japfa Comfeed Indonesia Company Information
- 7.14.2 Japfa Comfeed Indonesia Business Overview
- 7.14.3 Japfa Comfeed Indonesia Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.14.4 Japfa Comfeed Indonesia Poultry Vaccines Product Portfolio
- 7.14.5 Japfa Comfeed Indonesia Recent Developments
- 7.15 Nisseiken
- 7.15.1 Nisseiken Company Information
- 7.15.2 Nisseiken Business Overview
- 7.15.3 Nisseiken Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.15.4 Nisseiken Poultry Vaccines Product Portfolio
- 7.15.5 Nisseiken Recent Developments
- 7.16 Hile
- 7.16.1 Hile Company Information
- 7.16.2 Hile Business Overview
- 7.16.3 Hile Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.16.4 Hile Poultry Vaccines Product Portfolio
- 7.16.5 Hile Recent Developments
- 7.17 Hester Biosciences
- 7.17.1 Hester Biosciences Company Information
- 7.17.2 Hester Biosciences Business Overview
- 7.17.3 Hester Biosciences Poultry Vaccines Revenue and Gross Margin (2021-2026)
- 7.17.4 Hester Biosciences Poultry Vaccines Product Portfolio
- 7.17.5 Hester Biosciences Recent Developments
8 North America
- 8.1 North America Poultry Vaccines Revenue (2021-2032)
- 8.2 North America Poultry Vaccines Revenue by Type (2021-2032)
- 8.2.1 North America Poultry Vaccines Revenue by Type (2021-2026)
- 8.2.2 North America Poultry Vaccines Revenue by Type (2027-2032)
- 8.3 North America Poultry Vaccines Revenue Share by Type (2021-2032)
- 8.4 North America Poultry Vaccines Revenue by Application (2021-2032)
- 8.4.1 North America Poultry Vaccines Revenue by Application (2021-2026)
- 8.4.2 North America Poultry Vaccines Revenue by Application (2027-2032)
- 8.5 North America Poultry Vaccines Revenue Share by Application (2021-2032)
- 8.6 North America Poultry Vaccines Revenue by Country
- 8.6.1 North America Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Poultry Vaccines Revenue by Country (2021-2026)
- 8.6.3 North America Poultry Vaccines Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Poultry Vaccines Revenue (2021-2032)
- 9.2 Europe Poultry Vaccines Revenue by Type (2021-2032)
- 9.2.1 Europe Poultry Vaccines Revenue by Type (2021-2026)
- 9.2.2 Europe Poultry Vaccines Revenue by Type (2027-2032)
- 9.3 Europe Poultry Vaccines Revenue Share by Type (2021-2032)
- 9.4 Europe Poultry Vaccines Revenue by Application (2021-2032)
- 9.4.1 Europe Poultry Vaccines Revenue by Application (2021-2026)
- 9.4.2 Europe Poultry Vaccines Revenue by Application (2027-2032)
- 9.5 Europe Poultry Vaccines Revenue Share by Application (2021-2032)
- 9.6 Europe Poultry Vaccines Revenue by Country
- 9.6.1 Europe Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Poultry Vaccines Revenue by Country (2021-2026)
- 9.6.3 Europe Poultry Vaccines Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Poultry Vaccines Revenue (2021-2032)
- 10.2 China Poultry Vaccines Revenue by Type (2021-2032)
- 10.2.1 China Poultry Vaccines Revenue by Type (2021-2026)
- 10.2.2 China Poultry Vaccines Revenue by Type (2027-2032)
- 10.3 China Poultry Vaccines Revenue Share by Type (2021-2032)
- 10.4 China Poultry Vaccines Revenue by Application (2021-2032)
- 10.4.1 China Poultry Vaccines Revenue by Application (2021-2026)
- 10.4.2 China Poultry Vaccines Revenue by Application (2027-2032)
- 10.5 China Poultry Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Poultry Vaccines Revenue (2021-2032)
- 11.2 Asia Poultry Vaccines Revenue by Type (2021-2032)
- 11.2.1 Asia Poultry Vaccines Revenue by Type (2021-2026)
- 11.2.2 Asia Poultry Vaccines Revenue by Type (2027-2032)
- 11.3 Asia Poultry Vaccines Revenue Share by Type (2021-2032)
- 11.4 Asia Poultry Vaccines Revenue by Application (2021-2032)
- 11.4.1 Asia Poultry Vaccines Revenue by Application (2021-2026)
- 11.4.2 Asia Poultry Vaccines Revenue by Application (2027-2032)
- 11.5 Asia Poultry Vaccines Revenue Share by Application (2021-2032)
- 11.6 Asia Poultry Vaccines Revenue by Country
- 11.6.1 Asia Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Poultry Vaccines Revenue by Country (2021-2026)
- 11.6.3 Asia Poultry Vaccines Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Poultry Vaccines Revenue (2021-2032)
- 12.2 SAMEA Poultry Vaccines Revenue by Type (2021-2032)
- 12.2.1 SAMEA Poultry Vaccines Revenue by Type (2021-2026)
- 12.2.2 SAMEA Poultry Vaccines Revenue by Type (2027-2032)
- 12.3 SAMEA Poultry Vaccines Revenue Share by Type (2021-2032)
- 12.4 SAMEA Poultry Vaccines Revenue by Application (2021-2032)
- 12.4.1 SAMEA Poultry Vaccines Revenue by Application (2021-2026)
- 12.4.2 SAMEA Poultry Vaccines Revenue by Application (2027-2032)
- 12.5 SAMEA Poultry Vaccines Revenue Share by Application (2021-2032)
- 12.6 SAMEA Poultry Vaccines Revenue by Country
- 12.6.1 SAMEA Poultry Vaccines Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Poultry Vaccines Revenue by Country (2021-2026)
- 12.6.3 SAMEA Poultry Vaccines Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst